Showing results (1-10 of 26) with videos related to
Sort By:
Pageof 3
Artificial Cells, Nanomedicine, and Biotechnology|September 23, 2024
Dodecafluoropentane emulsion as an oxygen therapeuticJennifer L H Johnson, Evan UngerInternational Journal of Nanomedicine|October 17, 2018
Overcoming tumor hypoxia as a barrier to radiotherapy, chemotherapy and immunotherapy in cancer treatmentKaitlin Graham, Evan UngerAAPS Pharmscitech|April 6, 2006
Reformulation of a new vancomycin analog: an example of the importance of buffer species and strengthJennifer L H Johnson, Samuel H YalkowskyAAPS Pharmscitech|March 15, 2017
Reformulation of a new vancomycin analog: An example of the importance of buffer species and strengthJennifer L H Johnson, Samuel H YalkowskyAdvanced Drug Delivery Reviews|February 15, 2014
Cardiovascular drug delivery with ultrasound and microbubblesEvan Unger, Thomas Porter, Jonathan Lindner, et al.Journal of Pharmaceutical Sciences|July 29, 2003
Prediction of precipitation-induced phlebitis: a statistical validation of an in vitro modelJennifer L H Johnson, Yan He, Samuel H YalkowskyAAPS Pharmscitech|December 16, 2005
Oral formulation of a novel antiviral agent, PG301029, in a mixture of gelucire 44/14 and DMA (2:1, wt/wt)Yan He, Jennifer L H Johnson, Samuel H YalkowskyAAPS Pharmscitech|April 6, 2006
Improving cyclodextrin complexation of a new antihepatitis drug with glacial acetic acidJennifer L H Johnson, Yan He, Akash Jain, et al.AAPS Pharmscitech|March 15, 2017
Improving cyclodextrin complexation of a new antihepatitis drug with glacial acetic acidJennifer L H Johnson, Yan He, Akash Jain, et al.Intensive Care Medicine Experimental|June 15, 2023
The impact of intravenous dodecafluoropentane on a murine model of acute lung injuryJarrod M Mosier, Saad Sammani, Carrie Kempf, et al.Pageof 3